Selenium Suppresses Lipopolysaccharide-Induced Fibrosis in Peritoneal Mesothelial Cells Through Inhibition of Epithelial-to-Mesenchymal Transition
详细信息    查看全文
  • 作者:Jinyan Liu (1)
    Lingling Zeng (2)
    Yuliang Zhao (3)
    Bin Zhu (4)
    Wanjun Ren (4)
    Chunling Wu (4)
  • 关键词:Lipopolysaccharides ; Epithelial ; to ; mesenchymal transition ; Selenium ; Reactive oxygen species ; PI3K/AKT
  • 刊名:Biological Trace Element Research
  • 出版年:2014
  • 出版时间:November 2014
  • 年:2014
  • 卷:161
  • 期:2
  • 页码:202-209
  • 全文大小:1,264 KB
  • 参考文献:1. Zuo L, Wang M, Chinese Association of Blood Purification Management of Chinese Hospital Association (2010) Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 74(Suppl 1):S20–S22
    2. Modi GK, Jha V (2006) The incidence of end-stage renal disease in India: a population-based study. Kidney Int 70(12):2131-133
    3. Yang X, Yi C, Liu X et al (2013) Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 100(3):354-61 CrossRef
    4. Mehrotra R, Chiu YW, Kalantar-Zadeh K et al (2011) Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171(2):110-18 CrossRef
    5. Yeates K, Zhu N, Vonesh E et al (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 27(9):3568-575 CrossRef
    6. Ueno T, Nakashima A, Doi S et al (2013) Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int 84(2):297-07 CrossRef
    7. Kitamoto M, Kato K, Sugimoto A et al (2011) Sairei-to ameliorates rat peritoneal fibrosis partly through suppression of oxidative stress. Nephron Exp Nephrol 117(3):e71–e81 CrossRef
    8. de Lima SM, Otoni A, Sabino Ade P et al (2013) Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis. Clin Chim Acta 421:46-0 CrossRef
    9. Margetts PJ, Kolb M, Yu L et al (2001) A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 21:S368–S372
    10. Borges FR, Silva MD, Córdova MM et al (2014) Anti-inflammatory action of hydroalcoholic extract, dichloromethane fraction and steroid α-spinasterol from Polygala sabulosa in LPS-induced peritonitis in mice. J Ethnopharmacol 151(1):144-50 CrossRef
    11. Liu ZW, Zhu HT, Chen KL et al (2013) Selenium attenuates high glucose-induced ROS/TLR-4 involved apoptosis of rat cardiomyocyte. Biol Trace Elem Res 156(1-):262-70 CrossRef
    12. Yang SY, Zhang L, Miao KK et al (2013) Effects of selenium intervention on chronic fluorosis-induced renal cell apoptosis in rats. Biol Trace Elem Res 153(1-):237-42 CrossRef
    13. Cases J, Vacchina V, Napolitano A et al (2001) Selenium from selenium-rich Spirulina is less bioavailable than selenium from sodium selenite and selenomethionine in selenium-deficient rats. J Nutr 131(9):2343-350
    14. Babaknejad N, Sayehmiri F, Sayehmiri K et al (2014) The relationship between selenium levels and breast cancer: a systematic review and meta-analysis. Biol Trace Elem Res 159(1-):1- CrossRef
    15. Tarp U, Overvad K, Hansen JC et al (1985) Low selenium level in severe rheumatoid arthritis. Scand J Rheumatol 14(2):97-01 CrossRef
    16. Loscalzo J (2014) Keshan disease, selenium deficiency, and the selenoproteome. N Engl J Med 370(18):1756-760 CrossRef
    17. Naz?ro?lu M, Y?ld?z K, Tamtürk B et al (2012) Selenium and psoriasis. Biol Trace Elem Res 150(1-):3-
    18. Senol N, Naz?ro?lu M, Yürüker V (2014) N-Acetylcysteine and selenium modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic brain injury-induced rats. Neurochem Res 39(4):685-92 CrossRef
    19. Naz?ro?lu M, Karao?lu A, Orhan Aksoy A (2004) Selenium and high dose vit
  • 作者单位:Jinyan Liu (1)
    Lingling Zeng (2)
    Yuliang Zhao (3)
    Bin Zhu (4)
    Wanjun Ren (4)
    Chunling Wu (4)

    1. Department of Nephrology, Jining No.1 People’s Hospital, Jining, 272100, Shandong, People’s Republic of China
    2. Department of Nephrology, Xinhua hospital of Chengdu, Chengdu, 610066, Sichuan, People’s Republic of China
    3. Department of Nephrology, West China Hospital, West China School of Medicine, Sichuan University, Sichuan, 610041, People’s Republic of China
    4. Department of Nephrology and Hemodialysis, Jinan Central Hospital, Shandong University, No. 105, Jiefang Road, Jinan, 250013, Shandong, People’s Republic of China
  • ISSN:1559-0720
文摘
Peritoneal fibrosis resulting from long-term clinical peritoneal dialysis has been the main reason of dropout from peritoneal dialysis. Peritonitis as a common complication of peritoneal dialysis treatment may lead to the occurrences of peritoneal fibrosis. We cultured peritoneal mesothelial cells with lipopolysaccharides (LPS) in order to stimulate the environment of peritonitis and investigate whether lipopolysaccharides could induce epithelial-to-mesenchymal transition (EMT). Oxidative stress could stimulate fibrogenesis while selenium has antioxidant properties. So, this study also explored whether selenium supplementation affects lipopolysaccharide-induced EMT and fibrosis. We found that lipopolysaccharides could activate EMT changes such as the loss of E-cadherin and the increase of α-smooth muscle actin (α-SMA), collagen I, vimentin, and fibronectin (FN), while selenium inhibits EMT by modulating reactive oxygen species (ROS) generation and ROS/MMP-9 signaling pathways in peritoneal mesothelial cells. Moreover, it was revealed that selenium decreased the EMT events of peritoneal mesothelial cells via inhibition of PI3k/AKT pathways. In conclusion, these findings enable a better understanding of the mechanism of peritoneal fibrosis and explore a new idea for the prevention and treatment.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.